
Pharma Pulse 5/1/24: Tailoring AI Regulation in Healthcare, OpenAI and Microsoft Sued Over AI & more
The latest news for pharma industry insiders.
As adoption increases, regulatory bodies are becoming more involved in the oversight of artificial intelligence.
Researchers also found that there was variation in use of the insulin glargine interchangeable biosimilars across state Medicaid programs.
The suit, which accuses the tech companies of copyright infringement, adds to the fight over the online data used to power artificial intelligence.
Walmart said it will close all 51 of its health clinics and shut its virtual health care operations, saying it could not see it as a sustainable business model to continue.
Here are some tips to increase your metabolism and speed up the rate at which you burn calories and lose weight: https://wb.md/3w9bVEW
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

